WO2008078362A1 - 抗腫瘍剤及びこれを含有する食品 - Google Patents
抗腫瘍剤及びこれを含有する食品 Download PDFInfo
- Publication number
- WO2008078362A1 WO2008078362A1 PCT/JP2006/325624 JP2006325624W WO2008078362A1 WO 2008078362 A1 WO2008078362 A1 WO 2008078362A1 JP 2006325624 W JP2006325624 W JP 2006325624W WO 2008078362 A1 WO2008078362 A1 WO 2008078362A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- antitumor agent
- same
- food containing
- nerigoside
- bisdeoxynarciclasine
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 3
- JLPDBLFIVFSOCC-UHFFFAOYSA-N Oleandrin Natural products O1C(C)C(O)C(OC)CC1OC1CC(CCC2C3(CC(C(C3(C)CCC32)C=2COC(=O)C=2)OC(C)=O)O)C3(C)CC1 JLPDBLFIVFSOCC-UHFFFAOYSA-N 0.000 abstract 2
- SBTGHBALOCEVOR-PUZXQUAOSA-N (2s,3r,4s,4ar,11br)-2,3,4,7-tetrahydroxy-2,3,4,4a,5,11b-hexahydro-1h-[1,3]dioxolo[4,5-j]phenanthridin-6-one Chemical compound C1=C2[C@H]3C[C@H](O)[C@@H](O)[C@@H](O)[C@@H]3NC(=O)C2=C(O)C2=C1OCO2 SBTGHBALOCEVOR-PUZXQUAOSA-N 0.000 abstract 1
- SBTGHBALOCEVOR-UHFFFAOYSA-N 10balpha-Dihydro-Narciclasine Natural products C1=C2C3CC(O)C(O)C(O)C3NC(=O)C2=C(O)C2=C1OCO2 SBTGHBALOCEVOR-UHFFFAOYSA-N 0.000 abstract 1
- IWCNCUVTGOMGKG-UHFFFAOYSA-N 5alpha-oleandrigenin Natural products CC(=O)OC1CC2(O)C3CCC4CC(O)CCC4(C)C3CCC2(C)C1C1=CC(=O)OC1 IWCNCUVTGOMGKG-UHFFFAOYSA-N 0.000 abstract 1
- 241001654189 Lycoris aurea Species 0.000 abstract 1
- LZAZURSABQIKGB-AEKGRLRDSA-N Narciclasine Chemical compound C1=C2C3=C[C@H](O)[C@@H](O)[C@@H](O)[C@@H]3NC(=O)C2=C(O)C2=C1OCO2 LZAZURSABQIKGB-AEKGRLRDSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 244000187664 Nerium oleander Species 0.000 abstract 1
- DFDVWAJDFYYBAC-UHFFFAOYSA-N Oleaside A Natural products O1C(C)C(O)C(OC)CC1OC1CC(CCC23C4CCC(C)(C(C=5COC(=O)C=5)CC2)C3=O)C4(C)CC1 DFDVWAJDFYYBAC-UHFFFAOYSA-N 0.000 abstract 1
- AZOXLPPOBHVORY-UHFFFAOYSA-N UNPD104186 Natural products OC1C(O)C(O)C(C)OC1OC1CC2(O)CCC3C4(O)CCC(C=5COC(=O)C=5)C4(C)CC(O)C3C2(C=O)CC1 AZOXLPPOBHVORY-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- YBZZSZQZDODUAA-UHFFFAOYSA-N digitoxigenin alpha-L-cymaroside Natural products O1C(C)C(O)C(OC)CC1OC1CC(CCC2C3(CCC(C3(C)CCC32)C=2COC(=O)C=2)O)C3(C)CC1 YBZZSZQZDODUAA-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- VSEJCXBFXFEXPW-UHFFFAOYSA-N narciclasine Natural products OC1CC2=C(C(O)C1O)c3cc4OCOc4c(O)c3C(=O)N2 VSEJCXBFXFEXPW-UHFFFAOYSA-N 0.000 abstract 1
- IWCNCUVTGOMGKG-YOVVEKLRSA-N oleandrigenin Chemical compound C1([C@@H]2[C@@]3(C)CC[C@@H]4[C@@]5(C)CC[C@H](O)C[C@H]5CC[C@H]4[C@@]3(O)C[C@@H]2OC(=O)C)=CC(=O)OC1 IWCNCUVTGOMGKG-YOVVEKLRSA-N 0.000 abstract 1
- JLPDBLFIVFSOCC-XYXFTTADSA-N oleandrin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1C[C@@H](CC[C@H]2[C@]3(C[C@@H]([C@@H]([C@@]3(C)CC[C@H]32)C=2COC(=O)C=2)OC(C)=O)O)[C@]3(C)CC1 JLPDBLFIVFSOCC-XYXFTTADSA-N 0.000 abstract 1
- 229950010050 oleandrin Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
ナリゴシド、オレアンドリゲニン サルメントシド、オレアシドA、オレアンドリン、8β-ヒドロキシオドロシドA、ナルシクラシン、trans-ジヒドロナルシクラシン及びビスデオキシナルシクラシンからなる群から選ばれる少なくとも1種を含有する抗腫瘍剤を提供する。この抗腫瘍剤の有効成分は、キョウチクトウ及びショウキズイセンの抽出物から単離したものであり、優れた腫瘍治療効果を有し、副作用が少ないとの利点を有する。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2006/325624 WO2008078362A1 (ja) | 2006-12-22 | 2006-12-22 | 抗腫瘍剤及びこれを含有する食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/JP2006/325624 WO2008078362A1 (ja) | 2006-12-22 | 2006-12-22 | 抗腫瘍剤及びこれを含有する食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008078362A1 true WO2008078362A1 (ja) | 2008-07-03 |
Family
ID=39562161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2006/325624 WO2008078362A1 (ja) | 2006-12-22 | 2006-12-22 | 抗腫瘍剤及びこれを含有する食品 |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008078362A1 (ja) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102030796A (zh) * | 2010-10-22 | 2011-04-27 | 贵州省中国科学院天然产物化学重点实验室 | 从夹竹桃中分离出的几种强心苷化合物及其应用 |
KR101099651B1 (ko) * | 2008-10-24 | 2011-12-29 | 한국생명공학연구원 | 개상사화 추출물을 유효성분으로 함유하는 암 예방 및 치료용 또는 혈관신생 억제용 약학적 조성물 |
WO2012026641A1 (ko) | 2010-08-27 | 2012-03-01 | 한국과학기술연구원 | 치매의 예방 또는 치료용 조성물 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6322025A (ja) * | 1986-05-13 | 1988-01-29 | フセイン・ジ−ヤ・オ−ゼル | キョウチクトウ種抽出物からなる細胞増殖性疾患治療用組成物 |
WO2000047215A2 (en) * | 1999-02-12 | 2000-08-17 | Cellpath, Inc. | Methods for anti-tumor therapy |
JP2002526452A (ja) * | 1998-09-24 | 2002-08-20 | オゼル・ファーマスーティカルズ・インコーポレイテッド | キョウチクトウ抽出物、その医薬組成物及びその調整方法 |
JP2005289963A (ja) * | 2004-03-12 | 2005-10-20 | Hokubu Norin Koto Gakko Koenkai | 抗腫瘍剤 |
-
2006
- 2006-12-22 WO PCT/JP2006/325624 patent/WO2008078362A1/ja active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6322025A (ja) * | 1986-05-13 | 1988-01-29 | フセイン・ジ−ヤ・オ−ゼル | キョウチクトウ種抽出物からなる細胞増殖性疾患治療用組成物 |
JP2002526452A (ja) * | 1998-09-24 | 2002-08-20 | オゼル・ファーマスーティカルズ・インコーポレイテッド | キョウチクトウ抽出物、その医薬組成物及びその調整方法 |
WO2000047215A2 (en) * | 1999-02-12 | 2000-08-17 | Cellpath, Inc. | Methods for anti-tumor therapy |
JP2005289963A (ja) * | 2004-03-12 | 2005-10-20 | Hokubu Norin Koto Gakko Koenkai | 抗腫瘍剤 |
Non-Patent Citations (5)
Title |
---|
ABE F. ET AL.: "Oleasides; Novel Cardenolides with an Unusual Framework in Nerium (Nerium 10)", CHEMICAL & PHARMACEUTICAL BULLETIN, vol. 27, no. 7, 1979, pages 1604 - 1610, XP003022700 * |
ABE F. ET AL.: "Presence of Cardenolides and Ursolic acid from Oleander Leaves in Larvae and Frass of Daphnis Nerii", PHYTOCHEMISTRY, vol. 42, no. 1, 1996, pages 45 - 49, XP003023202 * |
PETTIT G.R. ET AL.: "Antineoplastic Agents. 527. Synthesis of 7-Deoxynarcistatin, 7-Deoxy-trans-dihydronarcistatin, and trans-Dihydronarcistatin 1", JOURNAL OF NATURAL PRODUCTS, vol. 68, no. 2, 2005, pages 207 - 211, XP003022699 * |
PETTIT G.R. ET AL.: "Antineoplastic Agents. 553. The Texas Grasshopper Brachystola magna", JOURNAL OF NATURAL PRODUCTS, vol. 68, no. 8, 2005, pages 1256 - 1258, XP003022698 * |
YAMACUHI T. ET AL.: "Quantitative Variations in the Cardiac Glycosides of Oleander", PHYTOCHEMISTRY, vol. 22, no. 10, 1983, pages 2211 - 2214, XP003023201 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101099651B1 (ko) * | 2008-10-24 | 2011-12-29 | 한국생명공학연구원 | 개상사화 추출물을 유효성분으로 함유하는 암 예방 및 치료용 또는 혈관신생 억제용 약학적 조성물 |
WO2012026641A1 (ko) | 2010-08-27 | 2012-03-01 | 한국과학기술연구원 | 치매의 예방 또는 치료용 조성물 |
JP2013537560A (ja) * | 2010-08-27 | 2013-10-03 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | 認知症の予防または治療用組成物 |
CN102030796A (zh) * | 2010-10-22 | 2011-04-27 | 贵州省中国科学院天然产物化学重点实验室 | 从夹竹桃中分离出的几种强心苷化合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007027894A3 (en) | Antisense compounds having enhanced anti-microrna activity | |
EP2586778A3 (en) | Pyridazinone derivatives useful as glucan synthase inhibitors | |
WO2006091395A3 (en) | Inhibitors of akt activity | |
WO2007011962A3 (en) | Treatment of cancer | |
WO2007086001A3 (en) | Novel pyridine derivatives | |
WO2006135627A3 (en) | Inhibitors of akt activity | |
WO2001012199A3 (en) | Methoxyamine potentiation of temozolomide anti-cancer activity | |
WO2008057512A3 (en) | Imidazopyrazines as protein kinase inhibitors | |
WO2008054676A3 (en) | Medical devices and methods of using the same | |
WO2006110638A3 (en) | Inhibitors of akt activity | |
WO2006110656A3 (en) | Compounds, compositions and methods for the treatment of viral infections and other medical disorders | |
WO2008106226A3 (en) | Macrolide compounds and methods of making and using the same | |
WO2006102610A3 (en) | Bicycloheteroaryl compounds as p2x7 modulators and uses thereof | |
WO2008139271A3 (en) | A synergistic pharmaceutical combination for the treatment of cancer | |
WO2005084365A3 (en) | Triptolide lactone ring derivatives as immunomodulators and anticancer agents | |
WO2009082134A3 (en) | Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as active agent | |
WO2008030883A3 (en) | Treatment of cancer | |
WO2007106537A3 (en) | Aminoquinolones as gsk-3 inhibitors | |
WO2008027600A3 (en) | Imatinib compositions | |
WO2007022956A3 (en) | Pharmaceutical compositions comprising a ph-dependent drug, a ph modifier and a retarding agent | |
WO2007146335A3 (en) | Compounds and compositions for treatment of cancer | |
WO2007048027A3 (en) | Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent | |
WO2005076888A3 (en) | Anti-cancer therapies | |
WO2008002460A3 (en) | Orally available light-independent antineoplastic compounds | |
WO2005085188A3 (en) | Compounds and methods for anti-tumor therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06843081 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06843081 Country of ref document: EP Kind code of ref document: A1 |